Washington Drug Letter
May 28, 2012
| Vol.
44 No.
22
Big Pharma Calls on Industry to Share Trial Results, End Ghostwriting
Eight major pharmaceutical companies are calling on drugmakers to publicize all clinical trial results — including unfavorable results — to address a “credibility gap” for industry-sponsored research.
This article is viewable by subscribers only. To view this article, please select an option below.
|